Pleno Inc.

Pleno Inc., founded in 2017 and headquartered in the United States, is an emerging player in the Biopharma, Biotechnology, and Health Care industries. The company is pioneering a multi-omic instrument platform designed to revolutionize biological target detection, enhancing clinical testing and biomedical research capabilities. Pleno aims to address a broad spectrum of applications ranging from screening and diagnostics to prognostics.

Adhering to its slogan of providing targeted biological information at unprecedented scale, precision, and performance, Pleno exemplifies innovative disruption in its field. The company's recent $25.00M Series B investment, led by notable entities such as Foresite Capital, Medical Excellence Capital, and Deerfield, underscores investor confidence in its growth potential and technological advancement.

With a focus on expanding their expert team, Pleno is positioned for significant impact, drawing on the dedicated collaboration of its scientists, engineers, and business professionals.